Ingredient
Tetrabutyl Ethylidenebisphenol
Tetrabutyl Ethylidenebisphenol is flagged for pregnancy, breastfeeding, trying to conceive, PCOS, postpartum and general use. The concern behind the strongest flag is endocrine disruptor and fetal development.
- TBEBP
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Last checked
- 15 September 2026
- The day this assessment was read from the catalogue
Tetrabutyl Ethylidenebisphenol and pregnancy
Not Recommended
- Endocrine disruptor
- Fetal development
- Absorbed into the body
Tetrabutyl ethylidenebisphenol is a synthetic antioxidant belonging to the bisphenol family, structurally related to compounds like BPA (bisphenol A). It's used in cosmetics to prevent oxidation and extend product shelf life. Bisphenol compounds are known endocrine disruptors that can mimic estrogen and interfere with hormone signaling. According to the Endocrine Society's scientific statement, exposure to endocrine-disrupting chemicals during pregnancy is particularly concerning because fetal development is exquisitely sensitive to hormone signals. While specific data on tetrabutyl ethylidenebisphenol in pregnancy is limited, its structural similarity to BPA and other concerning bisphenols raises significant flags. The compound can be absorbed through skin, potentially exposing the developing fetus during critical windows of development. Research published in Environmental Health Perspectives has linked bisphenol exposure during pregnancy to developmental effects. The EU's SCCS scrutinizes bisphenol compounds due to their endocrine disruption potential, and the FDA has expressed concern about BPA and related compounds. While this specific ingredient isn't explicitly prohibited, ACOG recommends that pregnant women minimize exposure to endocrine-disrupting chemicals when feasible alternatives exist. Most obstetricians and dermatologists advise avoiding bisphenol derivatives during pregnancy due to the precautionary principle, especially given the availability of well-studied antioxidant alternatives.
Tetrabutyl Ethylidenebisphenol and breastfeeding
Not Recommended
- Endocrine disruptor
- Passes into breast milk
- Infant exposure
Tetrabutyl ethylidenebisphenol is a bisphenol compound used as an antioxidant in cosmetics. Bisphenols are fat-soluble chemicals that can accumulate in body tissues and have been detected in breast milk. Research has shown that bisphenol compounds, including BPA and its analogs, can transfer into breast milk. A 2019 study in Environmental Science & Technology detected various bisphenol analogs in breast milk samples, demonstrating that these compounds can reach breastfed infants. Infant exposure is particularly concerning because babies have immature detoxification systems and higher susceptibility to endocrine disruption. The American Academy of Pediatrics has expressed concern about infant exposure to endocrine-disrupting chemicals through breast milk and other routes. While specific guidance on tetrabutyl ethylidenebisphenol is limited, toxicologists and pediatricians recommend minimizing exposure to bisphenol compounds during breastfeeding. The AAD notes that breastfeeding women should be cautious about ingredients that could transfer to infants through milk. Most lactation consultants and dermatologists advise choosing antioxidants with established safety profiles during breastfeeding.
Tetrabutyl Ethylidenebisphenol and postpartum
Caution Advised
- Endocrine disruptor
Tetrabutyl ethylidenebisphenol is a bisphenol antioxidant with potential endocrine-disrupting properties. During the postpartum period, hormone balance is already fluctuating as the body recovers from pregnancy. While not breastfeeding eliminates concerns about infant exposure, the ingredient's potential to interfere with hormone signaling remains a consideration during postpartum recovery. Women may prefer to avoid potential endocrine disruptors during this hormonally sensitive period, though the risk is lower than during pregnancy or breastfeeding.
Tetrabutyl Ethylidenebisphenol and trying to conceive
Not Recommended
- Endocrine disruptor
- Fertility effects
Tetrabutyl ethylidenebisphenol is a bisphenol compound with potential endocrine-disrupting activity. Research on bisphenol compounds has raised concerns about reproductive health and fertility effects. Studies on BPA and related bisphenols have found associations with reduced fertility and reproductive dysfunction. A 2018 review in Fertility and Sterility discussed how endocrine-disrupting chemicals, including bisphenols, may affect ovarian function and egg quality. While research specifically on tetrabutyl ethylidenebisphenol is limited, its structural similarity to studied bisphenols suggests similar concerns. Women trying to conceive are often advised to minimize exposure to endocrine disruptors during the preconception period to optimize fertility and prepare for healthy pregnancy. Many reproductive endocrinologists recommend avoiding bisphenol compounds when planning pregnancy.
Tetrabutyl Ethylidenebisphenol and PCOS
Not Recommended
- Endocrine disruptor
- Interferes with hormones
Tetrabutyl ethylidenebisphenol is a bisphenol compound with potential endocrine-disrupting properties. Bisphenols can interfere with hormone signaling and estrogen receptors. Women with PCOS already have disrupted hormone balance, characterized by elevated androgens and often insulin resistance. Research in journals like Environmental Health has linked bisphenol exposure to metabolic and endocrine dysfunction. Exposing the body to additional endocrine disruptors may theoretically worsen hormonal imbalances, though specific studies on tetrabutyl ethylidenebisphenol and PCOS are lacking. Some research suggests bisphenol exposure may affect insulin sensitivity and metabolic function. Endocrinologists and PCOS specialists generally recommend minimizing exposure to endocrine-disrupting chemicals. Women with PCOS who are actively managing their hormone balance may want to avoid bisphenol derivatives and choose antioxidants without endocrine activity. Cleaner alternatives can provide the same product stability benefits without hormonal concerns.
Tetrabutyl Ethylidenebisphenol and general use
Caution Advised
- Endocrine disruptor
Tetrabutyl ethylidenebisphenol is a synthetic antioxidant from the bisphenol family, used to prevent cosmetic product oxidation. It's structurally related to bisphenol A (BPA), a compound that has been removed from many consumer products due to health concerns. The primary concern with this ingredient is its potential for endocrine disruption. Bisphenol compounds can mimic hormones and interfere with the endocrine system's normal function. While BPA itself has been extensively studied and restricted in many applications, less is known about analogs like tetrabutyl ethylidenebisphenol. Research suggests that BPA alternatives may have similar concerning properties. The ingredient can be absorbed through skin, leading to systemic exposure. The European Union has increased scrutiny of bisphenol compounds in consumer products, and the SCCS evaluates these ingredients carefully. While not banned, growing scientific concern about endocrine disruption has led many formulators to seek alternatives. Consumers seeking to minimize exposure to potential hormone disruptors may prefer cosmetics using alternative antioxidants with more established safety profiles.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Tetrabutyl Ethylidenebisphenol, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store